IntegriChain

Blue Fin Group is a management and consulting firm that specializes in the pharmaceutical and biotech industries. Founded in 2001 and based in New York, the company provides research, strategy, and implementation services to assist manufacturers in developing cohesive commercial strategies. These strategies encompass various aspects of marketing, market access, field sales, pharmacy distribution, and patient services, all aimed at optimizing patient outcomes. The firm has a team of experienced consultants and access professionals who have worked with over 300 manufacturers, including those launching their first products and established global companies with diverse portfolios, such as cell and gene therapies, specialty drugs, and generics. Blue Fin Group also offers services like product strategy design, journey mapping, and commercial data analytics to enhance patient access to essential medicines.

Cumberland Consulting Group is a prominent healthcare consulting firm that provides a range of services to major payers, providers, and life sciences organizations. The firm specializes in IT advisory, implementation, optimization, and outsourcing, focusing on enhancing operational efficiency. Cumberland's Life Science Division offers advisory services, business process outsourcing, analytics solutions, and systems implementation related to contracts, pricing, and compliance for pharmaceutical manufacturers. As a vendor-neutral entity, the firm draws from a wide range of leading systems to offer clients objective recommendations tailored to their specific needs. Additionally, Cumberland provides strategic advisory services, managed services, project management, revenue cycle management, and legacy data management to assist clients in managing data abstraction, conversion, and archiving projects within enterprise environments. By prioritizing collaboration and understanding client challenges, Cumberland aims to deliver effective solutions that drive performance improvements.

daVIZta, Inc. specializes in revenue analytics and management solutions tailored for life sciences companies. Founded in 2010 and headquartered in Somerset, New Jersey, with an additional office in Pune, India, the company offers a suite of products, including the d-Rive suite, which supports finance and contracting professionals in managing revenue flows throughout the revenue lifecycle. This suite provides tools for pre-deal analysis, post-deal monitoring, and gross-to-net analysis, alongside the d-Rive VIZualizer, which visually communicates key metrics to enhance business intelligence efforts. In addition to its software solutions, daVIZta provides consulting, managed services, and data management, addressing critical needs within the life sciences sector. As of March 2019, the company operates as a subsidiary of IntegriChain Incorporated.

Medical Communication Technologies, Inc. specializes in government pricing and contracting software and services aimed at addressing the strategic challenges faced by biopharmaceutical manufacturers during product commercialization. Founded in 2000 and based in Acworth, Georgia, the company provides a range of services that include strategic reimbursement planning, patient services, and initiatives related to commercial payers, pharmacy benefit managers, and government contracting. Their offerings encompass government pricing services, rebate processing for both government and commercial sectors, commercialization and distribution planning, as well as trade relations and patient coupon rebate processing. As a subsidiary of IntegriChain Incorporated since February 2018, Medical Communication Technologies plays a vital role in supporting pharmaceutical, biotechnology, and medical device manufacturers throughout their operational processes.

PharmaMetrics, Inc. is a provider of contract operations outsourcing and market access analytics services tailored for the pharmaceutical industry. Founded in 1998 and based in Fort Washington, Pennsylvania, the company offers a range of services including Medicaid processing, Medicare Part D handling, pricing optimization, and formulary compliance. Additionally, PharmaMetrics specializes in contract advisory services, deal and market analysis, and comprehensive data management and analytics. Its clientele consists of both leading and emerging pharmaceutical companies, such as ThromboGenics, Actavis, ProStrakan, Novo Nordisk, Daiichi-Sankyo, and Bristol-Myers Squibb. As of April 2017, PharmaMetrics operates as a subsidiary of IntegriChain Incorporated. The company's services aim to streamline the complexities of managed market needs, providing clients with time and cost savings through a centralized platform for data and analysis.